Guide

Why employers overpay for specialty infusions—and how to take back control

Partner Insights from
Thank you for your interest. You can now access the asset below.
{download_button}

We've e-mailed a copy to the address you've provided: {email}
Welcome back.
You have registered as {email}. .

{download_button}

REGISTER NOW

For self-funded employers, specialty infusion is one of the fastest-growing and least transparent line items on a medical plan. Provider markups can exceed 400%, bundled into single claims with little visibility for the employer paying the bill.

This guide breaks down where the hidden costs live, and what a more transparent approach to specialty infusion spend could mean for your plan.

Inside, you'll learn:

  • The conditions and high-cost drugs driving the bulk of infusion spend
  • How provider markups get hidden inside a single bundled claim
  • A real-world pricing example with a 56% reduction on a single claim
  • How to address rising costs without disrupting care for your most vulnerable members
  • What "great" looks like when it comes to infusion benefit design